Synthesis and biological evaluation of benzimidazole-5-carbohydrazide derivatives as antimalarial, cytotoxic and antitubercular agents

José Camacho, Arthur Barazarte, Neira Gamboa, Juan Rodrigues, Rosario Rojas, Abraham Vaisberg, Robert H Gilman, Jaime Charris

Research output: Contribution to journalArticle

Abstract

A series of N′-substituted-2-(5-nitrofuran or 5-nitrothiophen-2-yl)- 3H-benzo[d]imidazole-5-carbohydrazide derivatives were synthesized and investigated for their abilities to inhibit β-hematin formation, hemoglobin hydrolysis and in vivo for their antimalarial efficacy in rodent Plasmodium berghei. Selected analogues were screened for their antitubercular activity against sensitive MTB H37Rv and multidrug-resistant MDR-MTB strains, and cytotoxic activity against a panel of human tumor cell lines and two nontumourogenic cell lines. Compounds 3a, 5a, f, 6g were the most promising as inhibitors of β-hematin formation, however, their effect as inhibitors of hemoglobin hydrolysis were marginal. The most active compounds to emerge from the in vitro and in vivo murine studies were 3a and 6i, suggesting an antimalarial activity via inhibition of β-hematin formation and are as efficient as chloroquine. The cytotoxic and antitubercular activities of the present compounds were not comparable with those of the standard drugs employed. But, however, compound 5b showed better antitubercular activity compared to rifampin against multidrug-resistant MDR-MTB strains. Compounds 3a, 6i and 5b showed a good safety index.

Original languageEnglish (US)
Pages (from-to)2023-2029
Number of pages7
JournalBioorganic and Medicinal Chemistry
Volume19
Issue number6
DOIs
StatePublished - Mar 15 2011
Externally publishedYes

Fingerprint

Antitubercular Agents
Hemin
Cytotoxins
Antimalarials
Derivatives
Hydrolysis
Hemoglobins
Cells
Nitrofurans
Plasmodium berghei
Chloroquine
Rifampin
Tumor Cell Line
Tumors
Rodentia
Safety
Cell Line
Pharmaceutical Preparations
carbohydrazide
benzimidazole

Keywords

  • β-Hematin
  • Antimalarial
  • Benzimidazole
  • Cancer
  • Plasmodium berghei
  • Tuberculosis

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Synthesis and biological evaluation of benzimidazole-5-carbohydrazide derivatives as antimalarial, cytotoxic and antitubercular agents. / Camacho, José; Barazarte, Arthur; Gamboa, Neira; Rodrigues, Juan; Rojas, Rosario; Vaisberg, Abraham; Gilman, Robert H; Charris, Jaime.

In: Bioorganic and Medicinal Chemistry, Vol. 19, No. 6, 15.03.2011, p. 2023-2029.

Research output: Contribution to journalArticle

Camacho, José ; Barazarte, Arthur ; Gamboa, Neira ; Rodrigues, Juan ; Rojas, Rosario ; Vaisberg, Abraham ; Gilman, Robert H ; Charris, Jaime. / Synthesis and biological evaluation of benzimidazole-5-carbohydrazide derivatives as antimalarial, cytotoxic and antitubercular agents. In: Bioorganic and Medicinal Chemistry. 2011 ; Vol. 19, No. 6. pp. 2023-2029.
@article{8fc9bef5f0eb4a70851ca0bb504377fd,
title = "Synthesis and biological evaluation of benzimidazole-5-carbohydrazide derivatives as antimalarial, cytotoxic and antitubercular agents",
abstract = "A series of N′-substituted-2-(5-nitrofuran or 5-nitrothiophen-2-yl)- 3H-benzo[d]imidazole-5-carbohydrazide derivatives were synthesized and investigated for their abilities to inhibit β-hematin formation, hemoglobin hydrolysis and in vivo for their antimalarial efficacy in rodent Plasmodium berghei. Selected analogues were screened for their antitubercular activity against sensitive MTB H37Rv and multidrug-resistant MDR-MTB strains, and cytotoxic activity against a panel of human tumor cell lines and two nontumourogenic cell lines. Compounds 3a, 5a, f, 6g were the most promising as inhibitors of β-hematin formation, however, their effect as inhibitors of hemoglobin hydrolysis were marginal. The most active compounds to emerge from the in vitro and in vivo murine studies were 3a and 6i, suggesting an antimalarial activity via inhibition of β-hematin formation and are as efficient as chloroquine. The cytotoxic and antitubercular activities of the present compounds were not comparable with those of the standard drugs employed. But, however, compound 5b showed better antitubercular activity compared to rifampin against multidrug-resistant MDR-MTB strains. Compounds 3a, 6i and 5b showed a good safety index.",
keywords = "β-Hematin, Antimalarial, Benzimidazole, Cancer, Plasmodium berghei, Tuberculosis",
author = "Jos{\'e} Camacho and Arthur Barazarte and Neira Gamboa and Juan Rodrigues and Rosario Rojas and Abraham Vaisberg and Gilman, {Robert H} and Jaime Charris",
year = "2011",
month = "3",
day = "15",
doi = "10.1016/j.bmc.2011.01.050",
language = "English (US)",
volume = "19",
pages = "2023--2029",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Synthesis and biological evaluation of benzimidazole-5-carbohydrazide derivatives as antimalarial, cytotoxic and antitubercular agents

AU - Camacho, José

AU - Barazarte, Arthur

AU - Gamboa, Neira

AU - Rodrigues, Juan

AU - Rojas, Rosario

AU - Vaisberg, Abraham

AU - Gilman, Robert H

AU - Charris, Jaime

PY - 2011/3/15

Y1 - 2011/3/15

N2 - A series of N′-substituted-2-(5-nitrofuran or 5-nitrothiophen-2-yl)- 3H-benzo[d]imidazole-5-carbohydrazide derivatives were synthesized and investigated for their abilities to inhibit β-hematin formation, hemoglobin hydrolysis and in vivo for their antimalarial efficacy in rodent Plasmodium berghei. Selected analogues were screened for their antitubercular activity against sensitive MTB H37Rv and multidrug-resistant MDR-MTB strains, and cytotoxic activity against a panel of human tumor cell lines and two nontumourogenic cell lines. Compounds 3a, 5a, f, 6g were the most promising as inhibitors of β-hematin formation, however, their effect as inhibitors of hemoglobin hydrolysis were marginal. The most active compounds to emerge from the in vitro and in vivo murine studies were 3a and 6i, suggesting an antimalarial activity via inhibition of β-hematin formation and are as efficient as chloroquine. The cytotoxic and antitubercular activities of the present compounds were not comparable with those of the standard drugs employed. But, however, compound 5b showed better antitubercular activity compared to rifampin against multidrug-resistant MDR-MTB strains. Compounds 3a, 6i and 5b showed a good safety index.

AB - A series of N′-substituted-2-(5-nitrofuran or 5-nitrothiophen-2-yl)- 3H-benzo[d]imidazole-5-carbohydrazide derivatives were synthesized and investigated for their abilities to inhibit β-hematin formation, hemoglobin hydrolysis and in vivo for their antimalarial efficacy in rodent Plasmodium berghei. Selected analogues were screened for their antitubercular activity against sensitive MTB H37Rv and multidrug-resistant MDR-MTB strains, and cytotoxic activity against a panel of human tumor cell lines and two nontumourogenic cell lines. Compounds 3a, 5a, f, 6g were the most promising as inhibitors of β-hematin formation, however, their effect as inhibitors of hemoglobin hydrolysis were marginal. The most active compounds to emerge from the in vitro and in vivo murine studies were 3a and 6i, suggesting an antimalarial activity via inhibition of β-hematin formation and are as efficient as chloroquine. The cytotoxic and antitubercular activities of the present compounds were not comparable with those of the standard drugs employed. But, however, compound 5b showed better antitubercular activity compared to rifampin against multidrug-resistant MDR-MTB strains. Compounds 3a, 6i and 5b showed a good safety index.

KW - β-Hematin

KW - Antimalarial

KW - Benzimidazole

KW - Cancer

KW - Plasmodium berghei

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=79952453594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952453594&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2011.01.050

DO - 10.1016/j.bmc.2011.01.050

M3 - Article

C2 - 21334900

AN - SCOPUS:79952453594

VL - 19

SP - 2023

EP - 2029

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 6

ER -